Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Safety Matters (to a Point)
Motley Fool
Saturday, November 17, 2012 - 2:02pm
tags:
Amarin Pushed Closer to Solo Vascepa Launch By Another NCE Delay
The Street
Saturday, November 17, 2012 - 2:01pm
tags:
Amarin, Vascepa, fish oil
Traders Eying Ampio Pharmaceuticals, With 3 Potential Blockbusters In The Red Zone
Seeking Alpha
Saturday, November 17, 2012 - 1:59pm
tags:
Ampio Pharmaceuticals, Ampion, Optina, Zertane, premature ejaculation, diabetic retinopathy, anti-inflammatories
AstraZeneca PLC (AZN): Today's Featured Drugs Laggard
The Street
Saturday, November 17, 2012 - 1:55pm
tags:
Astra Zeneca
What Are the Biggest Risks Facing VIVUS Today?
Motley Fool
Saturday, November 17, 2012 - 1:52pm
tags:
Vivus
This Week in Biotech: Part 2
Motley Fool
Saturday, November 17, 2012 - 1:49pm
tags:
Clovis Oncology, Eli Lilly, Celgene, Nektar, AstraZeneca, Salix, Progenics Pharmaceuticals, Dynavax Technologies, Tranzyme
This Week in Biotech: Part 1 (The Hep-C Chronicles)
Motley Fool
Saturday, November 17, 2012 - 1:47pm
tags:
Gilead Sciences, Abbott Laboratories, Idenix, Achillion, hepatitis C
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, November 17, 2012 - 1:46pm
tags:
Infinity, Sarepta Therapeutics, Gilead Sciences
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Peregrine Pharmaceuticals, Inc. To Contact The Firm
Yahoo/PR Newswire
Saturday, November 17, 2012 - 1:45pm
tags:
Peregrine Pharmaceuticals, lawsuits
After XTANDI's FDA Approval, Medivation Pulls Back
Seeking Alpha
Saturday, November 17, 2012 - 1:44pm
tags:
Xtandi, Medivation, prostate cancer
Sanofi Wins EU Backing for Drugs Against Diabetes, Cancer
Bloomberg
Saturday, November 17, 2012 - 1:42pm
tags:
Lyxumia, diabetes, Zaltrap, colorectal cancer
Hyperion Sees Volatility On Pending PDUFA And Rising Short Interest
Seeking Alpha
Saturday, November 17, 2012 - 1:41pm
tags:
Ravicti, urea cycle disorders, hepatic encephalopathy
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, November 17, 2012 - 1:36pm
tags:
Clovis Oncology, Dynavax Technologies, Nektar
Italy Lifts Ban on Novartis Vaccines
Yahoo/Zacks
Saturday, November 17, 2012 - 1:33pm
tags:
Novartis, vaccines, Agrippal, Fluad, flu vaccines
What Is So Exciting About MEI Pharma?
Seeking Alpha
Saturday, November 17, 2012 - 1:30pm
tags:
MEI Pharma, pracinostat, myelodysplastic syndrome
This Top-Dollar Drug Hits the Discount Rack
Motley Fool
Saturday, November 17, 2012 - 1:27pm
tags:
Sanofi, Dendreon, Regeneron, Zaltrap
Forest Inks Alzheimer's Drug Deal
Yahoo/Zacks
Friday, November 16, 2012 - 10:58am
tags:
Alzheimer's disease, Forest Labs, Namenda, Adamas Pharmaceuticals
Endo backs 2012 outlook, says Opana ER sales will recover in 2013 and later reach $800M a year
Yahoo/AP
Friday, November 16, 2012 - 10:57am
tags:
Endo Health Solutions, Opana ER
Biotech outfit Geron nears spinoff of stem cell business
Fierce Biotech
Friday, November 16, 2012 - 10:49am
tags:
Geron, stem cells
Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer
Bloomberg
Friday, November 16, 2012 - 10:43am
tags:
Sanofi, Europe, diabetes, Zaltrap, colorectal cancer, Lyxumia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.